Analyst firms · Morgan Stanley · SNN
Morgan Stanley SNN price target and rating history
Smith & Nephew SNATS Inc. (SNN) · Health Care
Morgan Stanley rates Smith & Nephew SNATS Inc. (SNN) Equal-Weight, as of its latest action on Sep 2, 2026. It has published 3 rating actions on SNN since October 2022, including 1 upgrade and 1 downgrade.
- Current rating
- Equal-Weight
- Price target
- Not stated
- Median target, all firms
- Too few
- Actions on SNN
- 3
Every Morgan Stanley rating on SNN
- Sep 2, 2026
- Apr 11, 2023
- Oct 18, 2022
How other firms rate SNN
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BofA Securities | Neutral | Sep 8, 2026 | |
| Morgan Stanley | Equal-Weight | Sep 2, 2026 | |
| BTIG | Neutral | Aug 31, 2026 | |
| Barclays | Underweight | Aug 5, 2026 | |
| Kepler Cheuvreux | Hold | Jun 4, 2026 | |
| RBC Capital Markets | Sector Perform | Dec 15, 2025 |
Questions about Morgan Stanley and SNN
- What is Morgan Stanley's rating on SNN?
- Morgan Stanley rates SNN Equal-Weight, a neutral rating, as of Sep 2, 2026.
- When did Morgan Stanley last change its view on SNN?
- On Sep 2, 2026, Morgan Stanley downgrades to Equal-Weight from Overweight.
More SNN rating histories
All Morgan Stanley ratingsSNN news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.